Molina Healthcare, Inc. filings document the regulatory record for a managed healthcare company serving Medicaid, Medicare and state insurance marketplace programs. Its 8-K reports disclose operating results, premium revenue and earnings guidance, Regulation FD investor presentations, material agreements, direct financial obligations, impairment charges and senior unsecured note financing.
The company's proxy and governance filings cover annual meeting proposals, director and executive compensation matters, equity incentive plan authorization and amendments to charter or bylaw provisions such as stockholder special-meeting rights. The filing record also describes capital-structure terms, credit agreement covenants, risk-factor references and shareholder voting outcomes.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard C. Zoretic received an equity grant of 405 shares of common stock on April 1, 2026, held by the Richard Charles Zoretic Revocable Living Trust. The grant was made under the company’s 2025 Equity Incentive Plan as part of his director compensation.
The shares were valued using the closing price of $135.82 on April 1, 2026, equating to a quarterly equity award of $55,000 and an annual equity award target of $220,000. Following this grant, the trust holds a total of 9,152 Molina Healthcare shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
MOLINA HEALTHCARE, INC. director Richard M. Schapiro received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The award represents one quarterly installment of a $220,000 annual equity grant, with this quarter’s $55,000 portion based on the $135.82 closing share price. Following the grant, Schapiro directly holds 12,074 common shares.
Molina Healthcare director Barbara L. Brasier received a grant of 405 shares of common stock as compensation for board service. The award was made on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The quarterly grant was valued at $55,000, based on the $135.82 closing price of Molina Healthcare stock that day. Brasier now directly holds 5,581 shares following this non‑market, compensation-related acquisition.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received an equity grant through a revocable trust. On April 1, 2026, the Ronna Romney Revocable Trust was awarded 405 shares of Molina Healthcare common stock at a reference price of $135.82 per share under the company’s 2025 Equity Incentive Plan. This quarterly grant represents one quarter of an annual director equity award valued at $220,000, structured as $55,000 in stock each quarter based on the closing market price that day. Following this award, the trust holds a total of 17,632 shares, reflecting routine, compensation-related ownership rather than an open-market purchase or sale.
Molina Healthcare Inc: The Vanguard Group filed an amended Schedule 13G/A reporting 0 shares and 0% beneficial ownership of common stock. The filing states an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report separately. The amendment is signed by Ashley Grim on 03/27/2026.
Molina Healthcare, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on five key items: electing ten directors for one-year terms, approving 2025 executive pay on an advisory basis, ratifying Ernst & Young LLP as 2026 auditor, expanding the 2025 Equity Incentive Plan share pool, and amending the Certificate of Incorporation to allow stockholders to call special meetings.
The Board highlights a government-focused growth strategy, serving about 5.5 million members across 21 states as of December 31, 2025, supported by multiple new Medicaid and Medicare contracts and the $350 million acquisition of ConnectiCare. Governance features include an independent chair, fully independent committees, director stock ownership guidelines, 12-year term limits for new independent directors, and a robust Board and committee evaluation process.
Molina Healthcare director Ronna Romney, through the Ronna Romney Revocable Trust, reported an open-market sale of 506 shares of Common Stock on March 12, 2026. The shares were sold at a volume-weighted average price of $146.92 per share, with individual trade prices ranging from $146.80 to $147.10.
Following this transaction, the trust continues to hold 17,227 Molina Healthcare shares indirectly attributed to Romney. The sale represents a relatively small portion of the trust’s overall reported holdings and appears as a routine portfolio adjustment rather than a large position change.
Molina Healthcare, Inc. is soliciting proxies for its 2026 Annual Meeting to be held virtually on May 6, 2026; stockholders of record as of March 9, 2026 may vote.
The proxy asks stockholders to: elect ten directors; approve an advisory say-on-pay vote for 2025 executive compensation; ratify Ernst & Young LLP as auditor for 2026; approve an amendment to the 2025 Equity Incentive Plan to increase shares available; and amend the Certificate of Incorporation to permit stockholders to call special meetings. The company reports serving approximately 5.5 million members as of December 31, 2025 and discloses notable recent contracts and the acquisition of ConnectiCare for $350 million effective February 1, 2025.
Filer: Fidelity Brokerage Services LLC filed a Form 144 reporting an intended sale of Common stock related to holdings on the NYSE.
The filing lists transaction identifiers including 506, 74220.08, and 51500000, and references 03/11/2026. The entries show prior stock awards dated 04/05/2023 (206 shares) and 01/02/2014 (300 shares).